China's vaccine frontrunner says its shots are safe, Canada flight cancelled over child without mask, Auto stocks bounce back in Europe and other pandemic-related news across the globe
The company is going ahead regardless of AsraZeneca pausing trials in UK after an adverse impact was reported
BCG vaccine, originally made against TB, is effective against various infections -- possibly also Covid-19, say researchers, adding that it also protects elderly people from respiratory infections
India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses
Quantitative antibody testing could also help with treatments involving convalescent plasma
Teachers and medical workers will be the first to get the Covid-19 vaccine jointly developed by the Gamaleya Research Institute and the Russian Defence Ministry
In a Q&A, pharma major's MD & CEO, R Ananthanarayanan says the firm is setting up a vaccine suite and is in final-stage talks with global players to seal a deal for developing a Covid-19 vaccine
Drugmakers say they first need to make sure the vaccines are safe and effective more generally
The company said it still expects adjusted earnings per share for the year to decline in the range of 1% to 4%
Under normal circumstances, the development of new vaccines and treatments could take 10-20 years
The Serum Institute of India first obtained the approval of the DCGI to conduct Phase I, II and III clinical trials of the vaccine in India
Lakshmi Mittal said, "This year has been a wake-up call to the world to be better prepared for pandemics, which, as we have all experienced, can cause massive social and economic disruption."
The British government said 300 healthy people will be immunized with two doses of the Covid-19 vaccine candidate developed at Imperial, which has been backed by 41 million pounds
The deal is the latest by AstraZeneca to pledge supply of its vaccine to governments who have scrambled to agree advance purchases of promising coronavirus vaccines
Saying that the world has been achieving a lot in knowing the new virus, the WHO chief told reporters that "there's still a lot we don't know"
Lilly has already launched human trials with two of the experimental therapies
The firm is set to make 500 million doses of the vaccine, which will then be supplied to the JV (based in the Republic of Ireland).
Remdesivir did not show signs of respiratory disease and had reduced damage to the lungs
Eli Lilly is collaborating with Junshi and Canadian biotech firm AbCellera Biologics to develop different antibody treatments
From how lockdown has changed human behavior, to New Zealand becoming Covid-free, and how coronavirus devastated the diamond world - read these and more in today's world dispatch